drugset / Trial / NCT02931357

Study of a New Medical Device in Gel Formulation Versus Calgel® for the Topical Treatment of Teething in Infants

NCT02931357

RandomizedParallel-groupOpen-labelTreatment

Summary

This is a randomized, open label, parallel-groups, multicenter study. The study will be conducted in three clinical sites. Test Medical Device: 0.54% Hyaluronic Acid rose honey flavour gel medical device class IIa.

Timeline

Start
2013-09
Primary completion
2013-09
Completion
2013-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cetylpyridinium Small molecule 0.1 % Topical
Comparator Lidocaine Other / unclassified 0.33 % Topical

Indications